KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Amortization of Deferred Charges (2017 - 2025)

Historic Amortization of Deferred Charges for Maxlinear (MXL) over the last 9 years, with Q4 2025 value amounting to $451000.0.

  • Maxlinear's Amortization of Deferred Charges fell 1770.07% to $451000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.9 million, marking a year-over-year decrease of 2399.53%. This contributed to the annual value of $1.9 million for FY2025, which is 2399.53% down from last year.
  • As of Q4 2025, Maxlinear's Amortization of Deferred Charges stood at $451000.0, which was down 1770.07% from $477000.0 recorded in Q3 2025.
  • Maxlinear's 5-year Amortization of Deferred Charges high stood at $1.2 million for Q2 2021, and its period low was $416000.0 during Q4 2021.
  • For the 5-year period, Maxlinear's Amortization of Deferred Charges averaged around $600150.0, with its median value being $530500.0 (2021).
  • In the last 5 years, Maxlinear's Amortization of Deferred Charges plummeted by 6161.37% in 2022 and then surged by 3703.7% in 2023.
  • Maxlinear's Amortization of Deferred Charges (Quarter) stood at $416000.0 in 2021, then grew by 23.32% to $513000.0 in 2022, then skyrocketed by 37.04% to $703000.0 in 2023, then decreased by 22.05% to $548000.0 in 2024, then decreased by 17.7% to $451000.0 in 2025.
  • Its last three reported values are $451000.0 in Q4 2025, $477000.0 for Q3 2025, and $491000.0 during Q2 2025.